Skip to main content
. 2018 May 14;118(11):1485–1491. doi: 10.1038/s41416-018-0093-y

Fig. 3.

Fig. 3

a Kaplan–Meier plots of median disease-free survival and overall survival for the overall CONKO-001 study group in dependence of a high and low tumour budding. b Kaplan–Meier plots of median disease-free survival and overall survival for the gemcitabine group and observation group of the CONKO-001 trial in dependence of high and low tumour budding